- Summits
- Sponsorship
- Retreats
- Media Opportunities
- News
- About
Every medical device company that sells implants, instruments, or loaner sets runs on a part of its business it can barely see: the field. The constantly moving network of consignment closets, rep trunk stock, and loaner kits that travels between hospitals and territories every day is where most inventory lives, where capital sits, and where value is quietly lost at a scale most teams never measure.
The reason it stays invisible is that most companies manage the field with spreadsheets, phone calls, and the memory of busy people. It works, right up until it doesn’t. And when it fails, it fails expensively.
Picture a dashboard showing clean totals and neat locations, everything apparently under control, except the data underneath went stale days ago, after a string of transfers and returns that happened by text and never hit the system. The dashboard still looks confident. It is describing a reality that no longer exists. We call this an inventory hallucination: when the system says product is there, but it isn’t. It drives confident, wrong decisions. Companies stockpile more inventory, product expires unwatched, and a single audit request triggers weeks of frantic reconstruction. It doesn’t show up as one clean line on the income statement. It hides inside write-offs, freight, and payroll, draining margin from a dozen places at once, which is exactly why it persists.
The usual fixes make it worse. More inventory just enlarges the record and deepens the blind spot. Generic software, built for a warehouse or a vendor’s idea of a standard workflow, breaks on the edge cases that define field work: the offline transfer, the return that doesn’t match the bill of materials, the consignment model that differs by customer. Newer AI tools that read reps’ texts and photos after the fact are cleanup, not prevention, and still depend on the gap forming first.
Skuvent was built on a different premise: field operations is not an inventory problem, it is an operations problem. Rather than layering reports on unreliable data, Skuvent captures every movement the moment it happens through structured workflows reps actually use, even offline, then reconciles cleanly without breaking the custody chain.
Reps, operations, and customers work in one platform, so the record stays true to reality. Visibility becomes the output of a reliable workflow, not a dashboard sitting on guesswork.
The impact is measurable. Customers reconcile inventory within 48 hours, cut manual coordination by roughly 40 percent, and complete field audits in as little as two days rather than the weeks manual reconstruction demands. Inventory that once went dark in the field becomes visible and accountable, turning a standing source of write-offs and emergency spend into something teams can finally control.
As devices converge on similar clinical performance, operational excellence becomes the differentiator. The next wave of medtech value is in everything that happens to the device after it leaves the warehouse. The companies that bring clarity to the field first will compound a structural edge. Skuvent exists to close that gap.
Book a demo at skuvent.com.
For MedTech companies serious about breaking into Asian markets, MedTech World Asia 2026 at the Hong Kong Convention and Exhibition Centre (26–28 August) is the right room. It brings together the region’s leading innovators, regulators, investors, and commercial decision-makers, and the host city makes it more than a conference. Hong Kong is the only city in Asia combining Western legal trust, direct China market access via CMDR 2026, GBA manufacturing reach, and a capital market with 1,500+ VC funds and the world’s #1 ranked exchange for biotech IPOs. If your Asia regulatory strategy is still taking shape, this is where it gets decided. Reserve your spot now.
